The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant-Reference-Cited by-同舟云学术

The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant

Published:2021-07-12 Issue:11 Volume:56 Page:2749-2754
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Alarcon Tomas Ana^ORCID,Whiting Karissa,Maloy Molly,Ruiz Josel D.,Devlin Sean,Sanchez-Escamilla Miriam,Yañez Lucrecia,Castillo Nerea,Pennisi Martina,Cho Christina,Shaffer Brian,Castro-Malaspina Hugo,Klimek Virginia,Giralt Sergio A.^ORCID,Tamari Roni,Perales Miguel-Angel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01392-w.pdf

Reference26 articles.

1. Tamari R, Castro-Malaspina H. Transplant for MDS: challenges and emerging strategies. Best Pract Res Clin Haematol. 2015;28:43–54.

2. D’Souza A, Lee S, Zhu X, Pasquini M. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23:1417–21.

3. Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, et al. CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse. Biol Blood Marrow Transplant. 2015;21:2106–14.

4. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.

5. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised International Prognostic Scoring System for myelodysplastic syndromes. Blood. 2012;120:2454–65.